Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myelomaSusan Bal, Jesús G. Berdeja, Allison Kaeding et al.|Blood|2026Cited by 1